Evidence map›Paper›PMID 24780147›Full record

ArticleResearch in developmental disabilities2014

Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder.

Kenneth D Gadow, Julia K Pinsonneault, Greg Perlman, Wolfgang Sadee

Open access · greenAbstract read
In one paragraph

Article in Research in developmental disabilities, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Neurochemistry of Autism.Brain sciences · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kenneth D GadowDepartment of Psychiatry, Stony Brook University, Stony Brook, NY 11794-8790, United States. Electronic address: kenneth.gadow@stonybrook.edu.
Julia K PinsonneaultDepartment of Pharmacology, Center in Pharmacogenomics, Ohio State University Wexner Medical Center, 333 West 10th Avenue, Columbus 43210, United States. Electronic address: pinsonneault.2@osu.edu.
Greg PerlmanDepartment of Psychiatry, Stony Brook University, Stony Brook, NY 11794-8790, United States. Electronic address: gperlman@gmail.com.
Wolfgang SadeeDepartment of Pharmacology, Center in Pharmacogenomics, Ohio State University Wexner Medical Center, 333 West 10th Avenue, Columbus 43210, United States. Electronic address: Wolfgang.Sadee@osumc.edu.
Stony Brook University · USThe Ohio State University Wexner Medical Center · US

Funding

Expression Genetics in Drug TherapyU01GM092655 · NIGMS · OHIO STATE UNIVERSITY · PI SADEE, WOLFGANG · 2010 to 2014
$8.6M
NIGMS NIH HHS U01 GM092655
6 · The paper itself

Abstract

The aim of the present study was to evaluate the association of dopaminergic gene variants with emotion dysregulation (EMD) and attention-deficit/hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorder (ASD). Three dopamine transporter gene (SLC6A3/DAT1) polymorphisms (intron8 5/6 VNTR, 3'-UTR 9/10 VNTR, rs27072 in the 3'-UTR) and one dopamine D2 receptor gene (DRD2) variant (rs2283265) were selected for genotyping based on à priori evidence of regulatory activity or, in the case of DAT1 9/10 VNTR, commonly reported associations with ADHD. A sample of 110 children with ASD was assessed with a rigorously validated DSM-IV-referenced rating scale. Global EMD severity (parents' ratings) was associated with DAT1 intron8 (ηp(2)=.063) and rs2283265 (ηp(2)=.044). Findings for DAT1 intron8 were also significant for two EMD subscales, generalized anxiety (ηp(2)=.065) and depression (ηp(2)=.059), and for DRD2 rs2283265, depression (ηp(2)=.053). DRD2 rs2283265 was associated with teachers' global ratings of ADHD (ηp(2)=.052). DAT1 intron8 was associated with parent-rated hyperactivity (ηp(2)=.045) and both DAT1 9/10 VNTR (ηp(2)=.105) and DRD2 rs2283265 (ηp(2)=.069) were associated with teacher-rated inattention. These findings suggest that dopaminergic gene polymorphisms may modulate EMD and ADHD symptoms in children with ASD but require replication with larger independent samples.

Indexed as

AdolescentAffective SymptomsAnxiety DisordersAttention Deficit Disorder with HyperactivityChildChild Development Disorders, PervasiveChild, PreschoolComorbidityDopamine Plasma Membrane Transport ProteinsEmotional IntelligenceFemaleGenetic VariationGenotypeHumansIntronsMajor Depressive DisorderDopamine Plasma Membrane Transport ProteinsDRD2 protein, humanReceptors, Dopamine D2SLC6A3 protein, humanADHDAutismAutism spectrum disorderDAT1DepressionDRD2Emotion dysregulation

Identifiers

PMID24780147
PMCPMC4084560
OpenAlexW2065893573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.